(859) 715-1116

Understanding Drug-Induced Psychosis

Drug-induced psychosis is a serious mental health condition that occurs when certain substances disrupt the brain’s normal functioning, leading to hallucinations, delusions, and disorganized thinking. This condition can be frightening for both individuals and their loved ones, often requiring immediate attention and specialized care. Yonder Behavioral Health is dedicated to helping adults and families understand, manage, and recover from drug-induced psychosis through compassionate, evidence-based treatment.

Recognizing the signs and causes of drug-induced psychosis is crucial for early intervention and successful recovery. With substance use and mental health challenges on the rise, understanding this condition empowers individuals to seek help and begin their journey toward healing. Yonder BH offers a supportive environment where clients can rebuild their lives and regain hope.

Yonder Behavioral Health’s Compassionate Approach to Drug-Induced Psychosis Treatment

Yonder BH believes every person’s journey is unique. Our approach combines evidence-based therapies with genuine compassion, ensuring clients feel safe and supported throughout treatment. The team works closely with clients and their families to create personalized plans that address both substance use and mental health needs.

By fostering a nurturing environment, Yonder BH helps individuals rediscover their strengths and build a foundation for lasting recovery. Our commitment to holistic care sets us apart as a trusted resource for those facing drug-induced psychosis.

What Is Drug-Induced Psychosis?

Drug-induced psychosis is a temporary or sometimes prolonged mental state caused by the use of certain substances. It is characterized by symptoms such as hallucinations, delusions, paranoia, and confusion. Drug-induced psychosis can occur after using drugs like methamphetamine, cocaine, cannabis, hallucinogens, or even some prescription medications. This condition can affect anyone who uses these substances, regardless of their mental health history.

How Drug-Induced Psychosis Differs From Other Mental Health Disorders

Unlike primary psychotic disorders such as schizophrenia, drug-induced psychosis is directly linked to substance use. Symptoms usually appear during or shortly after drug use and may resolve once the substance leaves the body. However, in some cases, symptoms can persist for weeks or even months.

It is important to distinguish drug-induced psychosis from other mental health conditions because the treatment approach may differ. Accurate diagnosis ensures individuals receive the most effective care for their specific needs.

What Causes Drug-Induced Psychosis?

Biological and Chemical Causes of Drug-Induced Psychosis

Drug-induced psychosis occurs when substances alter the brain’s chemical balance, particularly neurotransmitters like dopamine and serotonin. These changes disrupt normal thinking, perception, and behavior. Some individuals may be more sensitive to these effects due to genetic or biological factors.

Repeated exposure to certain drugs can cause long-lasting changes in brain function, increasing the risk of psychosis even after stopping use.

Substances Commonly Associated With Drug-Induced Psychosis

Several substances are known to trigger psychosis, including:

  • Stimulants (methamphetamine, cocaine, amphetamines)
  • Cannabis (especially high-potency strains)
  • Hallucinogens (LSD, PCP, psilocybin)
  • Synthetic drugs (spice, bath salts)
  • Prescription medications (steroids, certain antidepressants)

The risk of psychosis increases with higher doses, frequent use, and combining multiple substances.

The Impact of Dosage and Frequency on Drug-Induced Psychosis

Higher doses and frequent use of psychosis-inducing drugs greatly increase the risk of developing symptoms. Binge use or combining multiple substances can also make psychosis more likely and more severe. Even a single use of certain drugs, especially in large amounts, can trigger psychosis in some individuals. Chronic use raises the risk of persistent or recurring symptoms.

Underlying Health and Genetic Risk Factors for Drug-Induced Psychosis

Some people are more vulnerable to drug-induced psychosis due to:

  • Family history of mental illness
  • Pre-existing mental health conditions
  • Traumatic experiences or high stress
  • Genetic variations affecting brain chemistry

These factors can lower the threshold for psychosis, making it more likely to occur even with moderate substance use.

Symptoms of Drug-Induced Psychosis

Hallucinations and Delusions in Drug-Induced Psychosis

Hallucinations involve seeing, hearing, or feeling things that are not real. Delusions are false beliefs that persist despite evidence to the contrary. Both are hallmark symptoms of drug-induced psychosis and can be extremely distressing.

Individuals may believe they are being watched, followed, or controlled. These symptoms can lead to confusion, fear, and risky behaviors.

Behavioral and Emotional Symptoms of Drug-Induced Psychosis

Behavioral changes may include agitation, aggression, or social withdrawal. Emotional symptoms often involve intense fear, anxiety, or paranoia. Loved ones may notice sudden mood swings, erratic actions, or difficulty communicating. These changes can strain relationships and make daily life challenging.

Physical and Cognitive Signs of Drug-Induced Psychosis

Physical signs can include:

  • Rapid heartbeat
  • Sweating
  • Tremors
  • Insomnia

Cognitive symptoms may involve:

  • Disorganized thinking
  • Trouble concentrating
  • Memory problems

These symptoms can interfere with work, school, and personal responsibilities.

How Drug-Induced Psychosis Affects Daily Life and Relationships

Drug-induced psychosis can disrupt every aspect of life. Individuals may struggle to maintain employment, care for themselves, or interact with others. Relationships often suffer due to mistrust, fear, or misunderstandings.

Early intervention and support are essential to help individuals regain stability and rebuild connections with loved ones.

How Long Does Drug-Induced Psychosis Last?

Acute vs. Chronic Drug-Induced Psychosis

Acute drug-induced psychosis typically resolves within days to weeks after stopping substance use. However, some people experience chronic symptoms that persist for months or longer, especially with repeated drug exposure. The duration depends on the type of drug, amount used, and individual health factors. Chronic cases may require ongoing addiction treatment and support.

Several factors affect how long symptoms last:

  • Type and potency of the drug
  • Frequency and duration of use
  • Presence of underlying mental health conditions
  • Overall physical health

Prompt treatment can shorten the duration and reduce the risk of long-term complications.

Recovery Timeline and Prognosis for Drug-Induced Psychosis

Most people recover fully from drug-induced psychosis with proper treatment and abstinence from the triggering substance. Recovery may take several weeks, but some individuals need longer-term support.

Relapse is possible if substance use resumes, so ongoing care and relapse prevention are important for lasting recovery.

Why Understanding Drug-Induced Psychosis Is Important for Recovery

Drug-induced psychosis can be overwhelming, but understanding its causes and symptoms is the first step toward recovery. Many people experiencing this condition may not realize their symptoms are linked to substance use, which can delay treatment and worsen outcomes. Early recognition and intervention significantly improve the chances of a full recovery.

Families and individuals benefit from learning about drug-induced psychosis because it helps reduce stigma and encourages seeking professional help. Education also empowers loved ones to provide the right support during the recovery process.

Drug-Induced Psychosis vs. Primary Psychotic Disorders

Key Differences in Onset and Symptoms Between Drug-Induced and Primary Psychosis

Drug-induced psychosis usually begins soon after substance use and resolves when the drug leaves the body. Primary psychotic disorders, like schizophrenia, develop independently of substance use and often have a longer, more gradual onset. Symptoms may overlap, but the timing and triggers help clinicians distinguish between the two.

Diagnostic Challenges in Identifying Drug-Induced Psychosis

Diagnosing drug-induced psychosis can be challenging because symptoms mimic other mental health conditions. Accurate diagnosis requires a thorough assessment of substance use history, symptom onset, and medical background. Misdiagnosis can lead to inappropriate treatment, so it is important to work with experienced professionals.

Why Accurate Diagnosis of Drug-Induced Psychosis Matters

Correctly identifying drug-induced psychosis ensures individuals receive the right treatment. It also helps prevent unnecessary medication or interventions for primary psychotic disorders. Accurate diagnosis supports better outcomes and helps individuals and families understand what to expect during recovery.

Treatment for Drug-Induced Psychosis at Yonder Behavioral Health

Evidence-Based Therapies for Drug-Induced Psychosis

Yonder BH uses evidence-based therapies to address both the symptoms of psychosis and the underlying substance use. Treatment may include:

These approaches help clients manage symptoms, develop coping skills, and prevent relapse.

Personalized Drug-Induced Psychosis Treatment Plans

Each client receives a personalized treatment plan tailored to their unique needs and goals. The team considers factors such as substance use history, mental health, and family dynamics. Personalized care ensures clients receive the most effective interventions and support throughout their recovery journey.

Family and Loved One Support During Drug-Induced Psychosis Recovery

Yonder BH recognizes the importance of family involvement in recovery. We offer education, counseling, and support groups for loved ones to help them understand the condition and provide effective support.

Family therapy and participation can improve outcomes and strengthen relationships during and after treatment.

Aftercare and Relapse Prevention for Drug-Induced Psychosis

Aftercare programs are a vital part of recovery. Yonder BH provides ongoing support, relapse prevention planning, and access to community resources. Clients are encouraged to participate in follow-up care, support groups, and healthy activities to maintain their progress and prevent future episodes.

Frequently Asked Questions

Can Drug-Induced Psychosis Go Away Without Treatment?

In some cases, mild symptoms may resolve after stopping drug use, but professional treatment is recommended to ensure safety and prevent complications. Without treatment, symptoms can persist or worsen, especially if substance use continues.

What Are the Long-Term Effects of Drug-Induced Psychosis?

Long-term effects can include ongoing mental health challenges, cognitive difficulties, or increased risk of future psychotic episodes. Early intervention and abstinence from substances greatly reduce the risk of lasting problems.

How Do Doctors Diagnose Drug-Induced Psychosis?

Doctors diagnose drug-induced psychosis by reviewing substance use history, symptom onset, and conducting a thorough mental health assessment. Lab tests may be used to detect drugs in the system and rule out other causes.

Is Hospitalization Necessary for Drug-Induced Psychosis?

Hospitalization may be necessary if symptoms are severe, if there is a risk of harm, or if outpatient care is not sufficient. Many people can recover with outpatient treatment and strong support.

Can Drug-Induced Psychosis Happen More Than Once?

Yes, repeated substance use can trigger multiple episodes of drug-induced psychosis. Avoiding the triggering substances is the best way to prevent recurrence.

How Does Yonder Behavioral Health Support Recovery From Drug-Induced Psychosis?

Yonder BH provides comprehensive, compassionate care, including therapy, medication management, family support, and aftercare planning. Our personalized approach helps clients achieve lasting recovery and rebuild their lives.

Recovery From Drug-Induced Psychosis Is Possible

Recovery from drug-induced psychosis is achievable with the right support and treatment. Yonder Behavioral Health is committed to helping individuals and families navigate the challenges of substance use and mental health, offering a safe and nurturing environment for healing. Our evidence-based, compassionate approach empowers clients to regain control, rebuild relationships, and rediscover hope for the future.

If you or a loved one is experiencing symptoms of drug-induced psychosis, do not wait to seek help. Contact Yonder BH today to learn more about our programs and start the journey toward lasting recovery.

Compassionate, Comprehensive, and Personalized Care

These three ideas help define the care experience at Yonder Behavioral Health.

Compassionate care means you are treated like a person, not a problem. Our team knows it can be hard to ask for help, so we work to create a respectful, supportive space from the very beginning.

Comprehensive care means we look at the full picture of your life and health. Because addiction often overlaps with trauma, stress, and mental health concerns, treatment should address more than substance use alone.

Personalized care means your treatment plan is built around your needs, goals, and progress. Since recovery looks different for each person, the support you receive should feel specific, flexible, and relevant.

(859) 715-1116
Verify Insurance
Contact Us

About

Franklin Bland, Executive Director at Yonder Behavioral Health

Franklin Bland serves as Executive Director of Yonder Behavioral Health, bringing more than a decade of experience in the substance use disorder treatment field and a longstanding commitment to developing strong, compassionate teams.

Franklin holds a Bachelor of Health Administration from Capella University and has served in a variety of leadership roles throughout the SUD treatment field. He is intimately familiar with processes from the first call, to the ride to the next step in the recovery journey for those he has the honor of providing care for. Prior to entering healthcare, he spent approximately 20 years building and managing teams in the construction industry. Together, these experiences have shaped a leadership style centered on accountability, collaboration, mentorship, and the belief that exceptional client care begins with a cohesive and supported staff.

As a Mandt-trained leader, Franklin places a strong emphasis on trauma-informed care and expects staff interactions with patients to reflect dignity, respect, compassion, and an understanding of each individual’s experiences. He is passionate about mentoring employees, developing future leaders, and helping team members identify opportunities to advance in their own careers.

Franklin believes effective treatment must respect client autonomy, individual choice, and person-centered care. He recognizes that recovery is deeply personal and that there is no single path that works for everyone.

“Not all recovery looks the same, and every human deserves the chance to recover.”

As Executive Director, Franklin works to foster a culture in which compassionate care and accountability go hand in hand. He places a high value on interdepartmental collaboration and believes every department has a role in creating an environment where clients can feel safe, respected, and empowered to pursue lasting recovery.

Dr. William Cooke, Medical Director at Yonder Behavioral Health

Dr. William Cooke is the Medical Director of Yonder Behavioral Health, an inpatient facility dedicated to providing comprehensive and compassionate care for individuals struggling with substance use disorders. With over two decades of experience in addiction medicine, Dr. Cooke leads the clinical team with a focus on evidence-based practices and patient-centered care.

As a board-certified expert in both Family Medicine and Addiction Medicine, Dr. Cooke brings a holistic approach to treatment, integrating medical, psychological, and social support to address the complex needs of individuals on their journey to recovery. Under his leadership, Yonder BH emphasizes a “whole-person” philosophy, ensuring that each patient receives tailored treatment plans that foster long-term recovery and overall well-being.

Dr. Cooke is also a Fellow of the American Society of Addiction Medicine (ASAM), reflecting his commitment to advancing the field of addiction medicine through continuous learning, advocacy, and collaboration. He is dedicated to creating a safe, supportive, and effective environment where patients can begin their path to healing.

Norma Edwards is an accomplished Human Resources professional with more than 30 years of experience across human resources leadership, employee relations, recruitment, compliance, and organizational development. She has a proven track record of establishing and strengthening HR departments, developing effective systems and processes, and partnering with organizational leadership to support a strong and positive workplace culture.

Currently, Norma serves as Director of Human Resources at Yonder Behavioral Health / Aspen BHC, where she is an active member of the Leadership Team. She oversees all aspects of human resources and plays an integral role in supporting organizational compliance and operational effectiveness.

Throughout her career, Norma has successfully led human resources initiatives within new, rapidly growing, and established organizations. She is particularly experienced in building HR infrastructure from the ground up, developing effective policies and processes, and establishing collaborative partnerships with leaders throughout an organization.

Her professional experience spans the behavioral health, nonprofit, and hospitality industries, providing her with a broad perspective on workforce management, organizational culture, and employee engagement.

Jordan serves as the Director of Nursing at Yonder Behavioral Health and is passionate about helping individuals find hope, healing, and lasting recovery. She believes that every person deserves to be treated with dignity, compassion, and respect, especially during life’s most challenging moments.

Throughout her nursing career, Jordan has been dedicated to supporting individuals on their journey toward better health and wellness. Her approach is grounded in empathy, understanding, and the belief that meaningful connections can make a lasting impact on recovery.

Jordan is passionate about creating a supportive environment where patients feel safe, valued, and empowered to make positive changes in their lives. She is equally committed to encouraging teamwork, growth, and compassion among those who have the privilege of caring for others.

A strong advocate for recovery-focused care, Jordan believes in meeting people where they are and supporting them every step of the way. Her dedication to helping others and commitment to Yonder Behavioral Health’s mission continue to inspire patients and colleagues alike.

“I believe that every person deserves hope, compassion, and the opportunity to heal. Recovery is a journey, and it’s an honor to walk alongside individuals as they rediscover their strength and potential.”

Joshua Sherbert is a Kentucky native and serves as Program Director at Yonder Behavioral Health. He is passionate about creating a strong recovery culture built on connection, accountability, and support. Joshua believes in meeting people where they are while challenging them to recognize what they are capable of.

What he enjoys most about his work is building meaningful connections, developing a strong team, and watching people begin to believe in themselves as they build a better life through recovery.

Keisha Jones, LCSW, is an experienced behavioral health leader and licensed clinical social worker specializing in substance use disorder treatment, clinical operations, and patient-centered care. She earned her Master of Social Work degree from Campbellsville University, providing the foundation for a career dedicated to improving the lives of individuals and families impacted by mental health and substance use disorders.

With extensive experience in clinical leadership, Keisha has a strong background in developing high-performing teams, supervising and supporting clinicians, improving clinical programming, and maintaining high standards of quality and regulatory compliance. Her experience includes overseeing multidisciplinary clinical services, strengthening treatment programs, and promoting evidence-based, person-centered approaches to care.

Keisha is passionate about creating treatment environments where both patients and professionals can thrive. Her leadership approach emphasizes collaboration, accountability, compassion, and open communication while maintaining a strong commitment to clinical excellence.

Throughout her career, Keisha has remained dedicated to advancing the quality of behavioral health and addiction treatment and helping individuals build meaningful, sustainable lives in recovery.